This study supports the notion that the dysregulation of zinc in the brain triggers an imbalance in the nucleocytoplasmic distribution of SFPQ, with several studies reporting an elevated level of zinc in the serum and cerebrospinal fluid of ALS patients [21–23]. Here, SFPQ is linked to amyotrophic lateral sclerosis.